Susan Collins actually said...
We looked at Turing, we looked at Valeant, and what we found was a pattern of certain, what I call, hedge fund pharma companies buying the rights to a drug and then, overnight, increasing the cost by as much as literally 5,000 percent in the case of Daraprim.
10/16/2017